Schroder Investment Management Group
GHDX

Schroder Investment Management Group’s Genomic Health, Inc. GHDX Stock Holding History

Schroder Investment Management Group’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-22,682
Closed -$1.32M – 1344
2019
Q2 		$1.32M Buy
22,682
+8,063
+55% +$478K ﹤0.01% 869
2019
Q1 		$1.02M Buy
14,619
+3,274
+29% +$243K ﹤0.01% 896
2018
Q4 		$731 Buy
+11,345
New +$795K ﹤0.01% 932

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Schroder Investment Management Group's GHDX Position: Q3 2019 in Review

Schroder Investment Management Group sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 22,682 shares — an estimated $1.32M sold.

Schroder Investment Management Group first reported a position in GHDX in Q4 2018 and held it in 3 quarters. The position peaked at $1.32M in Q2 2019. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Schroder Investment Management Group reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Schroder Investment Management Group sold 22,682 Genomic Health, Inc. shares in Q3 2019, an estimated $1.32M.
  • Schroder Investment Management Group first reported a position in Genomic Health, Inc. in Q4 2018 and held it in 3 quarters.
  • Schroder Investment Management Group's Genomic Health, Inc. position peaked at $1.32M in Q2 2019.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Schroder Investment Management Group's 13F filing for Q3 2019, filed 12 Nov 2019.